Unternehmen Teva Pharmaceutical Industries Limited OTC Markets
Aktien
906517
IL0006290147
TEVJF
Pharmazeutika
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
14,7 USD | -18,33 % |
|
-18,33 % | +70,53 % |
25.06. | Teva Pharmaceutical zahlt $750 Millionen zur Beilegung von Steuerstreitigkeiten | MT |
25.06. | Teva erzielt Vereinbarung zur Beilegung anhängiger Steuerstreitigkeiten in Höhe von $750 Millionen | RE |
Kurzporträt
Mitarbeiterzahl: 35 737
Umsatz nach Geschäftsbereich
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Generics, Innovative Medicines and Over-the-counter Products
100,0
%
| 14 925 | 100,0 % | 15 846 | 100,0 % | +6,17 % |
Umsatz je Region
USD in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
North America
51,3
%
| 7 452 | 49,9 % | 8 124 | 51,3 % | +9,02 % |
Europe
30,5
%
| 4 525 | 30,3 % | 4 837 | 30,5 % | +6,90 % |
International
12,4
%
| 1 903 | 12,8 % | 1 958 | 12,4 % | +2,89 % |
Global
5,8
%
| 1 045 | 7,0 % | 926 | 5,8 % | -11,39 % |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 01.01.23 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 22.12.19 |
Kathleen Veit
CMP | Compliance Officer | - | 01.01.10 |
Eric Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 01.08.22 |
Amir Elstein
BRD | Director/Board Member | 67 | 01.01.95 |
Yael Ashman
IRO | Public Communications Contact | - | 01.09.09 |
Ran Meir
IRC | Investor Relations Contact | - | - |
Vikki Conway
HRO | Human Resources Officer | - | 01.01.10 |
Amir Weiss
AUD | Comptroller/Controller/Auditor | 47 | 01.06.12 |
Dov Bergwerk
SEC | Corporate Secretary | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 01.09.15 |
Janet Vergis
BRD | Director/Board Member | 59 | 09.06.20 |
Sol Barer
CHM | Chairman | 76 | 01.01.15 |
Roberto Mignone
BRD | Director/Board Member | 52 | 14.07.17 |
Amir Elstein
BRD | Director/Board Member | 67 | 01.01.95 |
Rosemary Crane
BRD | Director/Board Member | 64 | 01.09.15 |
Richard Francis
CEO | Chief Executive Officer | 55 | 01.01.23 |
Perry Nisen
BRD | Director/Board Member | 68 | 14.07.17 |
Tal Zaks
BRD | Director/Board Member | 58 | 01.10.21 |
Director/Board Member | 52 | 01.06.18 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 1 238 592 397 | 1 126 216 605 ( 90,93 %) | 106 000 000 ( 8,558 %) | 90,93 % |
Unternehmenskontakt
Teva Pharmaceutical Industries Ltd.
124 Dvora HaNevi'a Street
6944020, Tel Aviv
+972 3 914 8213
http://www.tevapharm.com![Straße Teva Pharmaceutical Industries Limited(TEVJF)](https://cdn.zonebourse.com/static/address/120788773.png)
Konzerngesellschaften
Name | Kategorie und Branche |
---|---|
Teva Czech Industries sro
![]() Teva Czech Industries sro Pharmaceuticals: MajorHealth Technology Part of Teva Pharmaceutical Industries Ltd., Teva Czech Industries sro develops drugs for pharmaceutical preparation. The company is based in Opava, Czechia. Jiri Urbanec has been the CEO of the Czech company since 2006. |
Pharmaceuticals: Major
|
Actavis Pharma Development Centre Pvt Ltd.
![]() Actavis Pharma Development Centre Pvt Ltd. Pharmaceuticals: GenericHealth Technology Founded in 2006, Actavis Pharma Development Centre Pvt Ltd. is a subsidiary of AbbVie, Inc. that develops, manufactures, and sells generic pharmaceutical products. The company is based in Mumbai, India. |
Pharmaceuticals: Generic
|
Teva Pharmaceutical Finance IV BV
|
Finance/Rental/Leasing
|
Teva Finance Services BV
![]() Teva Finance Services BV Finance/Rental/LeasingFinance Part of Teva Pharmaceutical Industries Ltd., Teva Finance Services BV is a Dutch company that provides finance services. The company is located in the Netherlands. |
Finance/Rental/Leasing
|
Teva Finance Services II BV
![]() Teva Finance Services II BV Finance/Rental/LeasingFinance Part of Teva Pharmaceutical Industries Ltd., Teva Finance Services II BV is a Dutch company that provides finance services. The company is located in the Netherlands. |
Finance/Rental/Leasing
|
Teva Pharmaceutical Finance Netherlands II BV
|
Finance/Rental/Leasing
|
Teva Pharmaceutical Finance Netherlands IV BV
|
Finance/Rental/Leasing
|
Teva Pharmaceutical Finance Netherlands III BV
|
Finance/Rental/Leasing
|
Actavis Holding Asia BV
![]() Actavis Holding Asia BV MiscellaneousMiscellaneous Part of AbbVie, Inc., Actavis Holding Asia holding company. The company is based in Haarlem, the Netherlands. |
Miscellaneous
|
Sektor
Umsatz je Region
![Analystenschätzungen](/images/consensus_flch.gif)
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+55,32 % | 819 Mrd. | |
-6,75 % | 351 Mrd. | |
+13,56 % | 329 Mrd. | |
+10,68 % | 298 Mrd. | |
+16,57 % | 242 Mrd. | |
+2,04 % | 225 Mrd. | |
+13,31 % | 217 Mrd. | |
+8,48 % | 168 Mrd. | |
-2,81 % | 158 Mrd. |
- Börse
- Aktien
- 883035 Aktie
- 906517 Aktie
- Unternehmen Teva Pharmaceutical Industries Limited